Phase 1 Clinical Trial of COVID-19 Vaccine UB-612
Mei Mei Hu, JD, co-founder and co-CEO and Peter Diamandis, MD, co-founder and vice chairman at COVAXX, a division of United Biomedical, discuss UB-612, ...
5264 articles
Mei Mei Hu, JD, co-founder and co-CEO and Peter Diamandis, MD, co-founder and vice chairman at COVAXX, a division of United Biomedical, discuss UB-612, ...
Rahul Aras, CEO of Iterion Therapeutics, a clinical stage biotechnology company developing novel cancer therapeutics discusses the company's lead produc...
Tiffany and Wil Cook share their experience living and coping with the diagnosis of Duchenne Muscular Dystrophy (DMD). When Will was homeschooled he t...
Bradley Marder, a nephrologist for nearly 20 years and now Medical Director of Nephrology at Horizon Therapeutics discusses working to educate other cli...
James Coffin, PhD, President and Chief Operating Officer at Sema4, a patient-center health intelligence digital company, discusses the new ability of th...
Gregg Sylvester, Chief Medical Officer at Seqirus discusses real-world evidence on the company’s MF59® Adjuvanted, Trivalent Influenza Vaccine that...
Cathy Kuhn, PharmD, Director of Strategy Consulting at Updox, the only place to manage healthcare communications across both in-person and virtual care,...
Gregg Sylvester, Chief Medical Officer at Seqirus discusses real-world evidence on the company’s cell-based quadrivalent influenza vaccine (QIVc), whi...
Huy Dang, DPM, discusses the condition of uncontrolled gout, his personal experience living with it, how it's impacted his day-to-day life, and how it h...
Dave Fuehrer, two-time cancer survivor and CEO of GRYT Health, and returning guest Wayne Eskridge, President and CEO of the Fatty Liver Foundation discu...